Data Bridge Market Research recently conducted an in-depth market intelligence study focusing on analyzing the Non-Opioid Pain Treatment Market. The newly released report adopts an engaging layout, utilizing visually appealing tables, graphs, charts, and figures to present vital data.

The Non-Opioid Pain Treatment market research report has been meticulously crafted through systematic collection and evaluation of market data within the industry. Its objective is to clarify crucial facts and figures for businesses, providing a comprehensive analysis of the market and its components. This includes aspects like market drivers, constraints, segmentation, opportunities, challenges, revenue insights, and competitive assessments. This resource empowers companies to make informed decisions within their specific market landscape.

A dedicated team comprising analysts, experts, statisticians, forecasters, and economists contributed rigorous efforts to produce this comprehensive and advanced Non-Opioid Pain Treatment market research report. It stands as a pivotal tool for maintaining a competitive edge over rivals. The report delves into market segmentation, categorizing potential customers based on various attributes such as product application, deployment models, end-user profiles, and geographical regions.

Moreover, the Non-Opioid Pain Treatment report offers insights into key players, significant collaborations, mergers, acquisitions, and emerging trends in innovation and business strategies. It consolidates precise and reliable market research data, offering businesses a clear roadmap for informed decision-making and strategic direction.

Data Bridge Market Research forecasts the non-opioid pain treatment market to reach USD 807.32 million by 2029, with an expected CAGR of 3.30% from 2022 to 2029. Alongside market insights such as value, growth rate, segments, geographical coverage, players, and scenario, the report includes expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework, providing a comprehensive perspective curated by the Data Bridge Market Research team.

 

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-opioid-pain-treatment-market

Pain management is an essential part of medical treatment. Migraine, lower back pain, osteoarthritis, fibromyalgia, localised musculoskeletal pain, and localised neuropathic pain are all examples of chronic pain syndromes. While opioids may be acceptable for acute or chronic pain related to palliative or end-of-life care, as well as current cancer therapy, there are also non-opioid pain management choices. Non-opioid pain treatment is an option for mild to moderate pain. Non-opioid pain relief is available without a prescription and as over-the-counter medications.

Key Growth Drivers:

  • Increasing prevalence of osteoarthritis

The rising global prevalence of osteoarthritis, fueled by the ageing population, joint injuries, obesity, repeated stress on the joint, genetics, metabolic illnesses, and bone abnormalities, is expected to fuel demand for non-opioid pain treatment patches. It is the most prevalent type of arthritis, and it most commonly affects the knees, hips, and hands. According to the Osteoarthritis Action Alliance (OAAA), approximately 54.4 million adults in the United States have some type of arthritis, with that number anticipated to rise to 78 million by 2040. Osteoarthritis affects roughly 32.5 million persons in the United States. This tendency is expected to continue in many regions of the world in the future years, propelling the market forward.

  • Increasing cases of cancer

Breast, bowel, colorectal, and lung cancer cases are predicted to increase in the next years, propelling the industry forward. The market is expected to benefit from increased awareness among governments in various countries about the availability of novel non-opioid heat patches for the treatment of cancer-related pain. According to the World Health Organization (WHO), cancer will kill approximately 10 million people worldwide in 2020. Breast cancer claimed over 6,85, 000 lives in the same year, while liver cancer claimed 8,30,000 lives and lung cancer claimed 1.80 million lives. This showcases that the prevalence of cancer is set to surge at a fast pace in the near future, which would drive the market.

The report outlines the involvement of key players, including:

Eli Lilly and company (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Centrexion Therapeutics Corp. (U.S), Acorda Therapeutics (U.S.), Biogen (U.S.), VM Biotech (U.S.), Novartis AG (Switzerland), Alder Biopharmaceuticals (U.S.), Sanofi (France), Pfizer Inc. (U.S.), GSK plc. (U.K.), Hisamitsu Pharmaceutical Co., Inc. (Japan), Clarion (U.S), Endo Pharmaceuticals (Ireland), TEH SENG PHARMACEUTICAL MFG. CO., LTD. (Taiwan), Veridian Healthcare (U.S.), Sorrento Therapeutics, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Teikoku Seiyaku Co. Ltd. (Japan)

Key Market Segmentation

Products (Medical Cannabis, Menthol- Containing, Omega 3 Fatty Acid Containing, Botulinum Toxins, Capsaicin Derived), Therapeutic Applications (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain), Drug Type (Acetaminophen, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Anticonvulsants, Serotoninnorepinephrine Reuptake Inhibitor Antidepressants), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-non-opioid-pain-treatment-market

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-mycophenolate-market

https://www.databridgemarketresearch.com/reports/global-variant-creutzfeldt-jakob-disease-treatment-market

https://www.databridgemarketresearch.com/reports/global-anti-money-laundering-market

https://www.databridgemarketresearch.com/reports/europe-anti-money-laundering-market

https://www.databridgemarketresearch.com/reports/asia-pacific-anti-money-laundering-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com